We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.17B
AUM Growth
-$340M
Cap. Flow
-$129M
Cap. Flow %
-2.5%
Top 10 Hldgs %
35.54%
Holding
104
New
3
Increased
29
Reduced
47
Closed
4

Top Buys

Rank Stock Value
1
RCI icon
Rogers Communications
RCI
+$35.5M
2
BCE icon
BCE
BCE
+$30.1M
3
PFE icon
Pfizer
PFE
+$23.7M
4
MRNA icon
Moderna
MRNA
+$19.7M
5
GSK icon
GSK
GSK
+$14.3M

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$50.9M
2
GILD icon
Gilead Sciences
GILD
+$34M
3
SU icon
Suncor Energy
SU
+$22.6M
4
MFC icon
Manulife Financial
MFC
+$21.9M
5
WFC icon
Wells Fargo
WFC
+$20.8M

Sector Composition

Rank Sector Weight
1 Financials 33.6%
2 Communication Services 17.84%
3 Materials 11.7%
4 Healthcare 9.67%
5 Technology 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
URTH icon
76
iShares MSCI World ETF
URTH
$8.14B
$1.15M 0.02%
7,400
– –
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$1.01M 0.02%
1,720
– –
ING icon
78
ING
ING
$105B
$776K 0.02%
49,551
– –
VTWO icon
79
Vanguard Russell 2000 ETF
VTWO
$16.8B
$625K 0.01%
7,000
– –
PBA icon
80
Pembina Pipeline
PBA
$27.5B
$505K 0.01%
13,682
+1,800
+15% +$73.4K
DUK icon
81
Duke Energy
DUK
$91.8B
$442K 0.01%
4,100
– –
FLIN icon
82
Franklin FTSE India ETF
FLIN
$2.56B
$427K 0.01%
+11,275
New +$445K
KMB icon
83
Kimberly-Clark
KMB
$32.8B
$396K 0.01%
3,025
– –
ALTM
84
DELISTED
Arcadium Lithium plc
ALTM
$376K 0.01%
73,250
– –
FTS icon
85
Fortis
FTS
$27.3B
$353K 0.01%
8,500
– –
VALE icon
86
Vale
VALE
$61.6B
$325K 0.01%
36,650
– –
MGTX icon
87
MeiraGTx Holdings
MGTX
$1.23B
$276K 0.01%
45,300
– –
MSFT icon
88
Microsoft
MSFT
$3.69T
$269K 0.01%
638
– –
SPRY icon
89
ARS Pharmaceuticals
SPRY
$423M
$261K 0.01%
24,700
– –
MET icon
90
MetLife
MET
$62.4B
$237K ﹤0.01%
2,900
– –
ALB icon
91
Albemarle
ALB
$13.4B
$213K ﹤0.01%
2,475
– –
GOOGL icon
92
Alphabet (Google) Class A
GOOGL
$4.22T
$207K ﹤0.01%
+1,092
New +$191K
MLYS icon
93
Mineralys Therapeutics
MLYS
$2.56B
$203K ﹤0.01%
16,500
+5,100
+45% +$66.7K
AURA icon
94
Aura Biosciences
AURA
$718M
$174K ﹤0.01%
21,200
– –
PLRX icon
95
Pliant Therapeutics
PLRX
$69.4M
$137K ﹤0.01%
10,400
– –
TCRX icon
96
TScan Therapeutics
TCRX
$21.8M
$110K ﹤0.01%
36,200
+15,500
+75% +$70.3K
ALDX icon
97
Aldeyra Therapeutics
ALDX
$82.6M
$86.3K ﹤0.01%
+17,300
New +$88.8K
ETNB
98
DELISTED
89bio
ETNB
$83.7K ﹤0.01%
10,700
– –
PROK icon
99
ProKidney
PROK
$364M
$26.9K ﹤0.01%
15,900
– –
OM icon
100
Outset Medical
OM
$59M
$15K ﹤0.01%
903
– –
1 2 3
4
5

Similar funds

JWBC
John W. Bristol & Co New York $6.76B AUM 18.39% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return

Letko, Brosseau & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Letko, Brosseau & Associates held 104 positions worth $5.17B, down 6.2% from $5.51B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Letko, Brosseau & Associates's Q4 2024 filing shows 3 new, 29 increased, 47 reduced and 4 closed positions. Its largest new stake was Franklin FTSE India ETF: 11,275 shares worth $427K. The largest sale was Celestica, an estimated $50.9M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Materials.

  • Letko, Brosseau & Associates's largest Q4 2024 buy was Franklin FTSE India ETF: 11,275 shares worth $427K.
  • Letko, Brosseau & Associates added most to Rogers Communications in Q4 2024, an estimated $35.5M increase.
  • Letko, Brosseau & Associates's biggest Q4 2024 reduction was Celestica, cutting an estimated $50.9M.
  • Letko, Brosseau & Associates fully exited Vodafone in Q4 2024, selling an estimated $13.6M.
  • Letko, Brosseau & Associates's ten largest holdings make up 36% of its $5.17B portfolio in Q4 2024.
  • Letko, Brosseau & Associates opened 3 new positions and closed 4 in Q4 2024.
  • Letko, Brosseau & Associates's portfolio value fell 6.2% quarter-over-quarter to $5.17B.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2024, filed 14 Feb 2025.